- Telehealth Visits
- Insurance plan information
Thiennu H. Vu, MD, PhD
She | Her | HersPulmonology- Telehealth Visits
- Insurance plan information
Thiennu H. Vu, MD, PhD
She | Her | HersPulmonology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Thiennu Vu is a pulmonologist who provides consultation and treatment for adults with lung diseases.
Vu earned her medical and doctoral degrees through the UCSF Medical Scientist Training Program. She completed a residency in internal medicine at the University of California, San Diego, and a fellowship in pulmonary and critical care medicine at UCSF.
Vu is a fellow of the American College of Chest Physicians.
Education & training
Board certification
- Pulmonary Disease, American Board of Internal Med/Pulmonary Disease
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Conditions
- Occupational Lung Injury
- Interstitial Lung Disease
- Emphysema
- Chronic Obstructive Pulmonary Disease
- Atypical Mycobacteria Infection
- Asthma
- Chronic Bronchitis
- Bronchitis
- Sarcoidosis
Locations
My research
Publications
Showing 1-6 of 8 reviews
- January 30, 20265 out of 5 Stars
Over many years Doctor Vu has made herself available to review my CT scans of my lung nodules. She takes the time to review options but luckily y they remain stable.
- April 25, 20255 out of 5 Stars
My doctor is very helpful
- April 18, 20255 out of 5 Stars
She is great I would never like to lose her.
- July 9, 20245 out of 5 Stars
Very caring doctor. She always knows my lab and Imaging results medication needs.
- June 7, 20245 out of 5 Stars
She's very professional, efficient, personable and a delight to work with on my health issue.
- April 20, 20245 out of 5 Stars
Excellent experience
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.